newsfilter
← Latest News
GlobeNewswire·

Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026

  • Aligos Therapeutics, Inc. (NASDAQ: ALGS) will report its first quarter 2026 financial results on Thursday, May 7, 2026, after the close of U.S. financial markets.
  • The company is a clinical stage biopharmaceutical focused on developing therapies for liver diseases, viral diseases, chronic hepatitis B, MASH, obesity, and coronaviruses.
  • Aligos filed its Annual Report on Form 10-K with the SEC on March 5, 2026, which details risks associated with its drug development process.
  • Jordyn Tarazi serves as Vice President, Investor Relations & Corporate Communications for Aligos.